Position in ARGX
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$48,849,873
+$8,740,162 QoQ
Shares Held
52,653
-4.1% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1
of 28 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Handelsbanken Fonder AB holds $686,434,691 across 88 Biotechnology names. ARGX ranks #3 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
218,292 | $108,432,185 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
631,899 | $49,458,734 | |
| 3 | ARGX |
Argenx SE
This page
|
52,653 | $48,849,873 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
212,275 | $39,754,862 | |
| 5 | CYTK |
Cytokinetics Inc
|
405,000 | $34,501,950 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
90,407 | $33,601,569 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
52,328 | $32,628,601 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
107,255 | $32,286,972 |
All Filings in ARGX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,849,873 | 52,653 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $40,109,711 | 54,926 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $44,299,564 | 52,678 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $30,317,403 | 41,105 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $21,912,648 | 39,753 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $22,520,463 | 38,050 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $20,692,905 | 33,647 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $14,984,175 | 27,642 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $11,790,836 | 27,418 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $10,481,220 | 26,621 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $9,835,256 | 25,853 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $13,503,109 | 27,466 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $10,172,732 | 26,102 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $7,156,516 | 19,208 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $7,567,129 | 19,975 | Shares | Sole | 2023-02-07 | |
| 2022-03-31 | $2,364,825 | 7,500 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $2,486,349 | 7,100 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,567,000 | 8,500 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,559,095 | 8,500 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $2,450,971 | 8,900 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $2,911,491 | 9,900 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,572,696 | 9,800 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,801,840 | 8,000 | Shares | Sole | 2020-08-26 | |
| No filing history on record for this holder in this stock. | ||||||